Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 studyShubham Pant, Christophe Le Tourneau, Toshihiko Doi et al.|The Lancet Oncology|2023Cited by 195
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatmentsAnna Minchom, Udai Banerji|PLoS ONE|2017Cited by 16